Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach

Therapeutics and Clinical Risk Management

Volumn 10, Issue 1, 2014, Pages 77-86

  Petridis, Dimitris ^a   Zarogoulidis, Paul ^b,c   Kallianos, Anastasios ^d   Kioumis, Ioannis ^b   Trakada, Georgia ^e   Spyratos, Dionysios ^b   Papaiwannou, Antonis ^b   Porpodis, Konstantinos ^b   Huang, Haidong ^f   Rapti, Aggeliki ^d   Hohenforst Schmidt, Wolfgang ^g   Zarogoulidis, Konstantinos ^b  

^a ALEXANDER TECHNOLOGICAL EDUCATIONAL INSTITUTE OF THESSALONIKI   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c RUHRLANDKLINIK   (Germany)

^d SOTIRIA GENERAL HOSPITAL   (Greece)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f SECOND MILITARY MEDICAL UNIVERSITY   (China)

^g UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

H1N1; H3N2; Influenza outbreak; Respiratory infection; Vaccination

Indexed keywords

EID: 84893870529     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/TCRM.S57429     Document Type: Article

References (48)

1. Zarogoulidis P, Constantinidis T, Steiropoulos P, Papanas N, Zarogoulidis K, Maltezos E. "Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?" BMC Res Notes. 2011;1(1):141.
2. Zarogoulidis P, Kouliatsis G, Papanas N, et al. Long-term respiratory follow-up of H1N1 infection. Virol J. 2011;8:319.
3. Zarogoulidis P, Glaros D, Kontakiotis T, et al. Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections. Int J Gen Med. 2012;5:175-182.
4. Shikov AN, Sementsova AO, Demina OK, et al. [Genetic variability of isolates of pandemic influenza A virus H1N1 isolated in Russia in 2009]. Mol Gen Mikrobiol Virusol. 2011;4:23-29. Russian.
5. Lackenby A, Moran Gilad J, Pebody R, et al. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill. 2011;16(5). pii: 19784.
6. Ravert RD, Fu LY, Zimet GD. Reasons for low pandemic H1N1 2009 vaccine acceptance within a college sample. Adv Prev Med. 2012;2012:242-518.
7. Cusumano-Towner M, Li DY, Tuo S, Krishnan G, Maslove DM. A social network of hospital acquired infection built from electronic medical record data. J Am Med Inform Assoc. 2013;20(3):427-434.
8. Park S, Kim JI, Lee I, et al. Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009-2011. J Microbiol. 2012; 50(6):1067-1070.
9. Chan KH, Chan KM, Ho YL, et al. Quantitative analysis of four rapid antigen assays for detection of pandemic H1N1 2009 compared with seasonal H1N1 and H3N2 influenza A viruses on nasopharyngeal aspirates from patients with influenza. J Virol Methods. 2012;186(1-2):184-188.
10. Park SJ, Kang BK, Jeoung HY, et al. Complete genome sequence of a canine-origin H3N2 feline influenza virus isolated from domestic cats in South Korea. Genome Announc. 2013;1(2):e0025312.
11. Klimov AI, Garten R, Russell C, et al; Writing Committee of the World Health Organization Consultation on Southern Hemisphere Influenza Vaccine Composition for 2012. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. Vaccine. 2012;30(45):6461-6471.
12. Wong KK, Greenbaum A, Moll ME, et al. Outbreak of influenza A (H3N2) variant virus infection among attendees of an agricultural fair, Pennsylvania, USA, 2011. Emerg Infect Dis. 2012;18(12):1937-1944.
13. Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, Viboud C. Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One. 2012;7(9):e45051.
14. Skowronski DM, Moser FS, Janjua NZ, et al. H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactions. PLoS One. 2013;8(1):e54015.
15. Pariani E, Amendola A, Ebranati E, et al. Genetic drift influenza A(H3N2) virus hemagglutinin (HA) variants originated during the last pandemic turn out to be predominant in the 2011-2012 season in Northern Italy. Infect Genet Evol. 2013;13:252-260.
16. Chan MC, Lee N, Ngai KL, et al. A "pre-seasonal" hospital outbreak of influenza pneumonia caused by the drift variant A/Victoria/361/2011-like H3N2 viruses, Hong Kong, 2011. J Clin Virol. 2013;56(3): 219-225.
17. Zhang YB, Chen JD, Xie JX, et al. Serologic reports of H3N2 canine influenza virus infection in dogs in Northeast China. J Vet Med Sci. 2013;75(8):1061-1062.
18. Lei N, Yuan ZG, Huang SF, et al. Transmission of avian-origin canine influenza viruses A (H3N2) in cats. Vet Microbiol. 2012;160(3-4): 481-483.
19. Li S, Shi Z, Jiao P, et al. Avian-origin H3N2 canine influenza A viruses in Southern China. Infect Genet Evol. 2010;10(8):1286-1288.
20. Wang H, Jia K, Qi W, et al. Genetic characterization of avian-origin H3N2 canine influenza viruses isolated from Guangdong during 2006-2012. Virus Genes. 2013;46(3):558-562.
21. Takemae N, Nguyen T, Ngo LT, et al. Antigenic variation of H1N1, H1N2 and H3N2 swine influenza viruses in Japan and Vietnam. Arch Virol. 2013;158(4):859-876.
22. Lin YP, Xiong X, Wharton SA, et al. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A. 2012;109(52):21474-21479.
23. Bragstad K, Emborg H, Fischer TK, et al. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13 - a rapid epidemiological and virological assessment. Euro Surveill. 2013;18(6). pii: 20397.
24. Skowronski DM, Janjua NZ, De Serres G, et al. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis. 2012;206(12): 1852-1861.
25. Popova L, Smith K, West AH, et al. Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses. PLoS One. 2012;7(7):e41895.
26. Wongphatcharachai M, Wang P, Enomoto S, et al. Neutralizing DNA aptamers against swine influenza H3N2 viruses. J Clin Microbiol. 2013;51(1):46-54.
27. Xu J, Huang D, Liu S, et al. Immune responses and protective efficacy of a recombinant swinepox virus co-expressing HA1 genes of H3N2 and H1N1 swine influenza virus in mice and pigs. Vet Microbiol. 2013;162(1):259-264.
28. Siqueira CM, Costa B, Amorim AM, et al. H3N2 homeopathic influenza virus solution modifies cellular and biochemical aspects of MDCK and J774G8 cell lines. Homeopathy. 2013;102(1):31-40.
29. Scotch M, Mei C. Phylogeography of swine influenza H3N2 in the United States: translational public health for zoonotic disease surveillance. Infect Genet Evol. 2013;13:224-229.
30. Greene G, Hood K, Little P, et al. Towards clinical definitions of lower respiratory tract infection (LRTI) for research and primary care practice in Europe: an international consensus study. Prim Care Respir J. 2011;20(3):299-306, 6 p following 306.
31. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360(25): 2605-2615.
32. Centers for Disease Control and Prevention (CDC). Update: infections with a swine-origin influenza A (H1N1) virus - United States and other countries, April 28, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(16): 431-433.
33. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis. 2007;44(8):1084-1088.
34. Curtain JP, Sankaran P, Kamath AV, Myint PK. The usefulness of confusion, urea, respiratory rate, and shock index or adjusted shock index criteria in predicting combined mortality and/or ICU admission compared to CURB-65 in community-acquired pneumonia. Biomed Res Int. 2013;2013:590407.
35. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. Characterization of the 1918 influenza virus polymerase genes. Nature. 2005;437(7060):889-893.
36. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-382.
37. Breiman L, Friedman J, Olshen RA, Stone CJ. Classification and Regression Trees. Monterey: Wadsworth and Brooks/Cole Advanced Books and Software; 1984:354.
38. Ritschard G. CHAID and earlier supervised tree methods [webpage on the Internet]. 2010. Available from: http://mephisto.unige.ch. Accessed July 24, 2013.
39. Greenacre MJ. Correspondence Analysis in Practice. 2nd ed. London: Academic Press; 2007:296.
40. Lee L, Warren, Slutsky S, Arthur, Mason, editors. Murray and Nadel's Textbook of Respiratory Medicine 4. Elsevier; 2005.
41. Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998;351(9101):467-471.
42. Woods CW, McClain MT, Chen M, et al. A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLoS One. 2013;8(1):e52198.
43. Ivan FX, Tan KS, Phoon MC, et al. Neutrophils infected with highly virulent influenza H3N2 virus exhibit augmented early cell death and rapid induction of type I interferon signaling pathways. Genomics. Epub November 27, 2012.
44. Rezaei F, Mirshafiey A, Shahmahmoodi S, Shoja Z, Ghavami N, Mokhtari-Azad T. Influenza virus-like particle containing two different subtypes of hemagglutinin confers protection in mice against lethal challenge with A/PR8 (H1N1) and A/HK (H3N2) viruses. Iran Red Crescent Med J. 2013;15(1):75-82.
45. Hurt AC, Deng YM, Ernest J, et al. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. Euro Surveill. 2011;16(3). pii: 19770.
46. Maurer-Stroh S, Lee RT, Eisenhaber F, Cui L, Phuah SP, Lin RT. A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virus. PLoS Curr. 2010;2:RRN1162.
47. Advisory Committee on Immunization Practices. Prevention and control of influenza with vaccines: interim recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013. MMWR Morb Mortal Wkly Rep. 2013;62(18):356.
48. Wiwanitkit V. Novel avian H7N9 influenza and its way to humans. J Formos Med Assoc. 2013;112(10):654.